Skip to main content
. 2018 Jun 4;8:8565. doi: 10.1038/s41598-018-26998-x

Figure 4.

Figure 4

A Pharmacophore model for fungal chorismate mutase inhibitors. The model was designed after studying the crystal structure of yeast chorismate mutase in complex with endo-oxabicyclic transition-state analogue inhibitor16. The established model composed of four pharmacophoric features.